SynaptixBio
About:
SynaptixBio is a biotechnology research company that develops lifesaving therapies for severe leukodystrophies.
Website: https://www.synaptixbio.com
Top Investors: Innovate UK
Description:
SynaptixBio is developing lifesaving therapies for severe leukodystrophies. The company enables the translation of ground-breaking research in TUBB4a Leukodystrophy into a transformative therapy. Their updated news is imported into the website. The customer queries are addressed through an online form.
Total Funding Amount:
13.5M GBP
Headquarters Location:
Oxford, Oxfordshire, United Kingdom
Founded Date:
2021-01-01
Founders:
Bent Jakobsen, Dan Williams, Michelle Teng
Number of Employees:
1-10
Last Funding Date:
2024-08-22
IPO Status:
Private
Industries:
© 2025 bioDAO.ai